Drugs for Dystonia, Focal, Task-Specific (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 14)
| # |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
| 1 |
|
Acetylcholine |
Approved |
Phase 3,Phase 2,Phase 1,Not Applicable |
|
51-84-3 |
187
|
|
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine Chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
|
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
| 2 |
|
Acetylcholine Release Inhibitors |
|
Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 3 |
|
onabotulinumtoxinA |
|
Phase 3,Not Applicable |
|
|
|
| 4 |
|
Cholinergic Agents |
|
Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 5 |
|
Neurotransmitter Agents |
|
Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 6 |
|
abobotulinumtoxinA |
|
Phase 3,Not Applicable |
|
|
|
| 7 |
|
Peripheral Nervous System Agents |
|
Phase 3,Phase 2,Not Applicable |
|
|
|
| 8 |
|
Neuromuscular Agents |
|
Phase 3,Phase 2,Not Applicable |
|
|
|
| 9 |
|
Botulinum Toxins, Type A |
|
Phase 3,Not Applicable |
|
|
|
| 10 |
|
Botulinum Toxins |
|
Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 11 |
|
incobotulinumtoxinA |
|
Phase 2,Not Applicable |
|
|
|
| 12 |
|
Flumazenil |
Approved |
|
|
78755-81-4 |
3373
|
|
Synonyms:
[3H]Ro15-1788
4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester
78755-81-4
8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
AC1L1FSE
AC1Q33UE
AC-6846
Anexate
Anexic acid
BIDD:GT0766
Biomol-NT_000285
BPBio1_001190
BRD-K98769987-001-01-3
BRN 4763661
C07825
C15H14FN3O3
CHEBI:5103
CHEMBL407
CID3373
CPD000058450
D005442
D00697
DB01205
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-5,6-dihydro-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
EU-0100506
F 6300
F6300_SIGMA
flumazenil
Flumazenil (JAN/USP/INN)
Flumazenil [USAN:BAN:INN]
Flumazenilo
Flumazenilo [Spanish]
Flumazenilum
Flumazenilum [Latin]
Flumazepil
Flumazepil, Ro 15-1788, Anexate, Lanexat, Mazicon, Roma,Flumazenil
HMS2051D17
HMS2089B15
Hoffman la roche brand OF flumazenil
Hoffman La Roche Brand of Flumazenil
Hoffman-la roche brand OF flumazenil
|
Hoffman-La Roche Brand of Flumazenil
I01-0379
Lanexat
Lopac0_000506
Lopac-F-6300
LS-77778
Mazicon
MLS000028850
MLS000759529
MLS001076354
MolPort-003-666-855
NCGC00015439-01
NCGC00015439-03
NCGC00015439-07
NCGC00025116-01
NCGC00025116-02
NCGC00025116-03
NCGC00025116-04
NCGC00025116-05
nchembio747-comp37
PDSP1_001778
PDSP2_001761
Ro 15 1788
Ro 151788
Ro 15-1788
Ro-?15-1788
Ro15-1788
Ro-15-1788
RO-151788
Roche brand OF flumazenil
Roche Brand of Flumazenil
Romazicon
Romazicon (TN)
S1332_Selleck
SAM001246763
SBB063113
SMR000058450
TL8005362
Tocris-1328
UNII-40P7XK9392
UPCMLD-DP137
UPCMLD-DP137:001
ZINC00001464
|
|
| 13 |
|
Insulin, Globin Zinc |
|
Not Applicable |
|
|
|
| 14 |
|
insulin |
|
Not Applicable |
|
|
|
Interventional clinical trials:
(show all 29)
| # |
Name |
Status |
NCT ID |
Phase |
Drugs |
| 1 |
Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity |
Recruiting |
NCT02326818
|
Phase 3 |
|
| 2 |
Transcranial Electrical Polarization to Treat Focal Hand Dystonia |
Completed |
NCT00106782
|
Phase 2 |
|
| 3 |
rTMS and Retraining in Focal Hand Dystonia |
Completed |
NCT01738581
|
Phase 1, Phase 2 |
|
| 4 |
Deep Brain Stimulation Surgery for Focal Hand Dystonia |
Recruiting |
NCT02911103
|
Phase 1, Phase 2 |
|
| 5 |
Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand |
Recruiting |
NCT02107261
|
Phase 2 |
incobotulinumtoxin A |
| 6 |
Motor Training to Treat Hand Dystonia |
Completed |
NCT00021853
|
Phase 2 |
|
| 7 |
Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp |
Completed |
NCT02015039
|
Phase 1, Phase 2 |
BoNT Injections |
| 8 |
Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia |
Completed |
NCT01884064
|
Phase 1 |
|
| 9 |
Somatosensory Processing in Focal Hand Dystonia |
Unknown status |
NCT00579033
|
Not Applicable |
|
| 10 |
Long-Term Motor Learning in Focal Hand Dystonia |
Completed |
NCT00325091
|
|
|
| 11 |
Muscle Contraction in Patients With Focal Hand Dystonia |
Completed |
NCT00376753
|
|
|
| 12 |
Effect of Increasing Motor Cortex Inhibition on Task Specific Dystonia |
Recruiting |
NCT01823237
|
Not Applicable |
|
| 13 |
Depotentiation in People With Focal Hand Dystonia |
Terminated |
NCT02106936
|
|
|
| 14 |
Neurophysiology of Task-Specificity of Focal Hand Dystonia |
Completed |
NCT00309010
|
|
|
| 15 |
Brain Changes in Patients With Focal Hand Dystonia |
Completed |
NCT00306865
|
|
|
| 16 |
fMRI Studies of Task Specificity in Focal Hand Dystonia |
Completed |
NCT00310414
|
|
|
| 17 |
Transcranial Magnetic Stimulation for Focal Hand Dystonia |
Suspended |
NCT01792336
|
|
|
| 18 |
Impact Of Physiotherapy And Botox In Improving Functional Outcomes Among Post Stroke Focal Dystonia Patients |
Completed |
NCT03664375
|
Not Applicable |
|
| 19 |
Movement-Related Brain Networks Involved in Hand Dystonia |
Completed |
NCT00137384
|
|
|
| 20 |
Brain Networks in Dystonia |
Enrolling by invitation |
NCT03042962
|
|
|
| 21 |
Pathophysiology of Dystonia and Complex Regional Pain Syndrome |
Recruiting |
NCT03223623
|
|
|
| 22 |
Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia |
Recruiting |
NCT02334683
|
Not Applicable |
|
| 23 |
Brain Anatomy in Dystonia |
Terminated |
NCT00031369
|
|
|
| 24 |
EEG and EMG Studies of Hand Dystonia |
Completed |
NCT00025701
|
|
|
| 25 |
Transcranial Magnetic Stimulation and Electrical Stimulation of Nerves to Study Focal Dystonia |
Completed |
NCT00050024
|
|
|
| 26 |
Validation of the Zigzag Tracking Task Test for the Evaluation of Handwriting Difficulties in Writer's Cramp |
Recruiting |
NCT02882295
|
|
|
| 27 |
Sensory Training to Treat Focal Dystonia |
Completed |
NCT00006336
|
|
|
| 28 |
Validating a New Writer s Cramp Scale |
Completed |
NCT01579266
|
|
|
| 29 |
Association Between Focal Dystonia and Complex Regional Pain Syndrome |
Completed |
NCT00595439
|
|
|
|
